Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia

Molecular Psychiatry

Volumn 8, Issue 11, 2003, Pages 911-915

  Glatt, S J ^a,b   Faraone, S V ^a,b,e   Tsuang, M T ^a,b,c,d,e  

^a MASSACHUSETTS MENTAL HEALTH CENTER   (United States)

^b Harvard Inst Psychiat E   (United States)

^c Psychiatry Service   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Association; D2 receptor; Dopamine; Gene; Meta analysis; Schizophrenia

Indexed keywords

DOPAMINE 2 RECEPTOR; RECEPTOR SUBTYPE;

AGE DISTRIBUTION; ALLELE; ARTICLE; CALCULATION; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHNOLOGY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RECEPTOR GENE; SCHIZOPHRENIA;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; RISK FACTORS; SCHIZOPHRENIA;

EID: 0242552588     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001321     Document Type: Article

References (32)

1. Seeman P. Atypical antipsychotics: mechanism of action. Can J Psychiatry 2002; 47: 27-38.
2. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1987; 1: 133-152.
3. Itokawa M, Arinami T, Futamura N, Hamaguchi H, Toru M. A structural polymorphism of human dopamine D2 receptor, D2(Ser311→Cys). Biochem Biophys Res Commun 1993; 196: 1369-1375.
4. Arinami T, Itokawa M, Enguchi H, Tagaya H, Yano S, Shimizu H et al. Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 1994; 343: 703-704.
5. Cravchik A, Sibley DR, Gejman PV. Functional analysis of the human D2 dopamine receptor missense variants. J Biol Chem 1996; 271: 26013-26017.
6. Verga M, Macciardi F, Pedrini S, Cohen S, Smeraldi E. No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a classical case control study and the haplotype relative risk. Schizophr Res 1997; 25: 117-121.
7. Arinami T, Itokawa M, Aoki J, Shibuya H, Ookubo Y, Iwawaki A et al. Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders. Am J Med Genet 1996; 67: 133-138.
8. Asherson P, Williams N, Roberts E, McGuffin M, Owen M. DRD2 Ser311/ Cys311 polymorphism in schizophrenia. Lancet 1994; 343: 1045.
9. Crawford F, Hoyne J, Cai X, Osborne A, Poston D, Zaglul J et al. Dopamine DRD2/Cys311 is not associated with chronic schizophrenia. Am J Med Genet 1996; 67: 483-484.
10. Gejman PV, Ram A, Gelernter J, Friedman E, Cao Q, Pickar D et al. No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. J Am Med Assoc 1994; 271: 204-208.
11. Harano M. Ser-311-Cys polymorphism of the dopamine D2 receptor gene and schizophrenia - an analysis of schizophrenic patients in Fukuoka. Kurume Med J 1997; 44: 201-208.
12. Hattori M, Nanko S, Dai XY, Fukuda R, Kazamatsuri H. Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia. Biochem Biophys Res Commun 1994; 202: 757-763.
13. Himei A, Koh J, Sakai J, Inada Y, Akabame K, Yoneda H. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms. Psychiatry Clin Neurosci 2002; 56: 97-102.
14. Hori H, Ohmori O, Shinkai T, Kojima H, Nakamura J. Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia. Am J Med Genet 2001; 105: 176-178.
15. Kaneshima M, Higa T, Nakamoto H, Nagamine M. An association study between the Cys311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan population. Psychiatry Clin Neurosci 1997; 51: 379-381.
16. Laurent C, Bodeau-Pean S, Campion D, d'Amato T, Jay M, Dollfus S et al. No major role for the dopamine D2 receptor Ser→Cys311 mutation in schizophrenia. Psychiatr Genet 1994; 4: 229-230.
17. Nanko S, Hattori M, Dai XY, Fukuda R, Kazamatsuri H. DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet 1994; 343: 1044.
18. Ohara K, Nakamura Y, Xie DW, Ishigaki T, Deng ZL, Tani K et al. Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia. Biol Psychiatry 1996; 40: 1209-1217.
19. Serretti A, Lattuada E, Lorenzi C, Lilli R, Smeraldi E. Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses. Mol Psychiatry 2000; 5: 270-274.
20. Shaikh S, Collier D, Arranz M, Ball D, Gill M, Kerwin R. DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet 1994; 343: 1045-1046.
21. Sobell J, Sigurdson DC, Heston L, Sommer S. S311C D2DR variant: no association with schizophrenia. Lancet 1994; 344: 621-622.
22. Tanaka T, Igarashi S, Onodera O, Tanaka H, Fukushima N, Takahashi M et al. Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia. Am J Med Genet 1996; 67: 208-211.
23. Chen CH, Chien SH, Hwu HG. No association of dopamine D2 receptor molecular variant Cys 311 and schizophrenia in Chinese patient. Am J Med Genet (Neuropsych Genet) 1996; 67: 418-420.
24. Fujiwara Y, Yamaguchi K, Tanaka Y, Tomita H, Shiro Y, Kashihara K et al. Polymorphism of dopamine receptors and transporter genes in neuropsychiatric diseases. Eur Neurol 1997; 38 (Suppl 1); 6-10.
25. Spurlock G, Williams J, McGuffin P, Aschauer HN, Lenzinger E, Fuchs K et al. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. Am J Med Genet (Neuropsych Genet) 1998; 81: 24-28.
26. Nothen MM, Wildenauer D, Cichon S, Albus M, Maier W, Minges J et al. Dopamine D2 receptor molecular variant and schizophrenia. Lancet 1994; 343: 1301-1302.
27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986; 7: 177-188.
28. Woolf B. On estimating the relation between blood group and disease. Annu Eugen 1955; 19: 251-253.
29. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
30. Williams J, McGuffin P, Nothen M, Owen MJ. Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia. Lancet 1997; 349: 1221.
31. Dubertret C, Gorwood P, Ades J, Feingold J, Schwartz JC, Sokoloff P. Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians. Am J Med Genet 1998; 81: 318-322.
32. Sasaki T, Macciardi FM, Badri F, Verga M, Meltzer HY, Lieberman J et al. No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis. Am J Med Genet (Neuropsych Genet) 1996; 67: 415-417.